NCT01085565View on ClinicalTrials.gov

Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Bone CancerBone MetastasesPain
Interventions
DEVICE

ExAblate 2100

Conformal Bone System

Trial Locations (1)

52621

Sheba MC, Ramat Gan

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY

NCT01085565 - Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System | Biotech Hunter | Biotech Hunter